Institutions / PSP Research LLC
PSP Research LLC
CIK 2106939 · Institution · as of Dec 31, 2025
Portfolio value
$114.42M
Positions
85
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 85 →
| Company | Value | % of portfolio |
|---|---|---|
| iShares Tr | $70.27M | 61.4% |
| Praxis Precision Medicines, Inc. | $584.2K | 0.5% |
| Travere Therapeutics, Inc. | $583.5K | 0.5% |
| Tyra Biosciences, Inc. | $574.5K | 0.5% |
| Pharvaris N.V. | $569.2K | 0.5% |
| Jazz Pharmaceuticals PLC | $553.9K | 0.5% |
| Celldex Therapeutics, Inc. | $553.2K | 0.5% |
| CG Oncology, Inc. | $551.9K | 0.5% |
| Belite Bio, IncBLTE | $550.7K | 0.5% |
| Ascendis Pharma A/S | $549.9K | 0.5% |
| Apellis Pharmaceuticals, Inc. | $549.3K | 0.5% |
| Terns Pharmaceuticals, Inc. | $547.8K | 0.5% |
| Revolution Medicines, Inc. | $547.4K | 0.5% |
| Centessa Pharmaceuticals PLC | $547.2K | 0.5% |
| BridgeBio Pharma, Inc. | $546.1K | 0.5% |
| Nurix Therapeutics, Inc. | $544.7K | 0.5% |
| Arcutis Biotherapeutics, Inc. | $543.5K | 0.5% |
| Kodiak Sciences Inc.KOD | $542.9K | 0.5% |
| Immunome Inc. | $542.3K | 0.5% |
| Aurinia Pharmaceuticals Inc.AUPH | $541.5K | 0.5% |
| Mirum Pharmaceuticals, Inc. | $541.4K | 0.5% |
| Halozyme Therapeutics Inc | $540.1K | 0.5% |
| EyePoint, Inc. | $539.5K | 0.5% |
| Alkermes plc. | $539.5K | 0.5% |
| Ionis Pharmaceuticals Inc | $537.9K | 0.5% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.